Literature DB >> 1756174

Murine cyclophilin-S1: a variant peptidyl-prolyl isomerase with a putative signal sequence expressed in differentiating F9 cells.

A Schumacher1, H Schröter, G Multhaup, A Nordheim.   

Abstract

Fractionation of differentiating murine teratocarcinoma F9 cells and extraction of the nuclear/microsomal pellets with ethidium bromide led to the purification and microsequencing of the protein mCyP-S1, a novel cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase (PPIase). mCyP-S1 is a new member of the cyclophilin class of proteins. Cloning and sequencing of the mCyP-S1 cDNA revealed extended coding capacity for a putative N-terminal signal sequence, suggesting processing of mCyP-S1 during intracellular translocation across the membrane of the endoplasmic reticulum. mCyP-S1 is abundantly expressed in a variety of mouse organ tissues and its mRNA levels increase during F9 cell differentiation. Specific subcellular localization of PPIases is postulated to contribute to functional specificities of this class of enzymes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756174     DOI: 10.1016/0167-4781(91)90207-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  A cyclophilin from the polycentric anaerobic rumen fungus Orpinomyces sp. strain PC-2 is highly homologous to vertebrate cyclophilin B.

Authors:  H Chen; X L Li; L G Ljungdahl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

2.  DNA sequence analysis of a cyclophilin gene from maize: developmental expression and regulation by salicylic acid.

Authors:  J Marivet; P Frendo; G Burkard
Journal:  Mol Gen Genet       Date:  1995-04-20

Review 3.  Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression.

Authors:  A Schumacher; A Nordheim
Journal:  Clin Investig       Date:  1992-09

4.  Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease.

Authors:  A Kratz; M W Harding; J Craft; C G Mackworth-Young; R E Handschumacher
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.